parkinson's disease (pd)

Showing 1 - 25 of 29

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Parkinson's Disease (PD), Movement Disorders, Depression Trial in Changhua (probiotics, Placebo)

Not yet recruiting
  • Parkinson's Disease (PD)
  • +3 more
  • probiotics
  • Placebo
  • Changhua, Taiwan
    Changhua Christian Hospital (CCH)
Nov 6, 2023

ABBV-951 Subcutaneous Infusion to Assess Change in Disease

Not yet recruiting
  • Parkinson's Disease (PD)
    • (no location specified)
    Oct 25, 2023

    Subcutaneous Infusion of ABBV-951 to Assess Change in Disease

    Not yet recruiting
    • Parkinson's Disease (PD)
      • (no location specified)
      Jun 15, 2023

      Symptomatic Neurogenic Orthostatic Hypotension, MSA, Parkinson's Disease (PD) Trial in Worldwide (ampreloxetine, Placebo)

      Terminated
      • Symptomatic Neurogenic Orthostatic Hypotension
      • +3 more
      • Sun City, Arizona
      • +81 more
      Dec 29, 2022

      Parkinson's Disease (PD) Trial in Australia, United States (ABBV-951)

      Enrolling by invitation
      • Parkinson's Disease (PD)
      • Birmingham, Alabama
      • +52 more
      Oct 17, 2022

      Parkinson's Disease (PD) Trial in Worldwide (ABBV-951)

      Completed
      • Parkinson's Disease (PD)
      • Birmingham, Alabama
      • +64 more
      Sep 23, 2022

      Parkinson's Disease (PD) Trial in Worldwide (ABBV-951)

      Enrolling by invitation
      • Parkinson's Disease (PD)
      • Birmingham, Alabama
      • +49 more
      Jan 18, 2022

      Quality of Life in LCIG Patients and LCIG Eligible Patients

      Completed
      • Parkinson's Disease (PD)
        • Aachen, Nordrhein-Westfalen, Germany
        • +26 more
        Dec 7, 2020

        Parkinson's Disease (PD) Trial in Worldwide (Optimized antiparkinsonian treatment, Levodopa-Carbidopa Intestinal Gel (LCIG),

        Completed
        • Parkinson's Disease (PD)
        • Optimized antiparkinsonian treatment
        • +4 more
        • Port Charlotte, Florida
        • +27 more
        Aug 10, 2020

        Mono- and cOmbination Therapy With Levodopa-carbidopa inteStinal

        Completed
        • Parkinson's Disease (PD)
          • Hermagor-Pressegger See, Kaernten, Austria
          • +29 more
          Dec 17, 2019

          Parkinson's Disease Using Magnetic Resonance Imaging (MRI)

          Completed
          • Parkinson's Disease (PD)
          • +3 more
            • Hershey, Pennsylvania
              Penn State Milton S. Hershey Medical Center and College of Medic
            Jan 2, 2020

            Parkinson's Disease (PD) Trial in United States (ABBV-951)

            Completed
            • Parkinson's Disease (PD)
            • Glendale, California
            • +6 more
            Nov 13, 2019

            Parkinson's Disease (PD) Trial in United States (ABBV-951)

            Completed
            • Parkinson's Disease (PD)
            • Sun City, Arizona
            • +11 more
            Mar 12, 2019

            Dyskinesia, Levodopa-Induced Dyskinesia (LID), Parkinson's Disease (PD) Trial in Worldwide (ADS-5102, Placebo)

            Completed
            • Dyskinesia
            • +2 more
            • Fountain Valley, California
            • +50 more
            Jan 9, 2018

            Parkinson's Disease (PD) Trial in Kenmore (Intranasal glutathione - (in)GSH, Saline Intranasal Delivery)

            Completed
            • Parkinson's Disease (PD)
            • Intranasal glutathione - (in)GSH
            • Saline Intranasal Delivery
            • Kenmore, Washington
              Bastyr Clinical Research Center
            Jul 27, 2017

            Alzheimer's Disease (AD), Parkinson's Disease (PD), Chronic Traumatic Encephalopathy (CTE) Trial in New Haven ([18F]T807

            Completed
            • Alzheimer's Disease (AD)
            • +6 more
            • [18F]T807 ([18F]MNI-777)
            • New Haven, Connecticut
              Molecular NeuroImaging, LLC
            Dec 15, 2016

            Parkinson's Disease (PD) Trial in Paris (BIA 9-1067, Entacapone, Placebo)

            Completed
            • Parkinson's Disease (PD)
            • BIA 9-1067
            • +3 more
            • Paris, France
              SGS aster
            Jul 29, 2016

            Parkinson's Disease (PD) Trial (Placebo, BIA 3-202, Comtan®)

            Completed
            • Parkinson's Disease (PD)
            • Placebo
            • +3 more
            • (no location specified)
            Jul 13, 2016

            Parkinson's Disease (PD) Trial in S. Mamede do Coronado (BIA 3-202, Placebo, levodopa 100 mg / benserazide 25 mg)

            Completed
            • Parkinson's Disease (PD)
            • BIA 3-202
            • +2 more
            • S. Mamede do Coronado, Portugal
              Human Pharmacology Unit
            Jun 13, 2016

            Parkinson's Disease (PD) Trial in Rueil (BIA 9-1067, Placebo)

            Completed
            • Parkinson's Disease (PD)
            • BIA 9-1067
            • Placebo
            • Rueil, Malmaison, France
              BIOTRIAL
            Nov 23, 2015

            Parkinson's Disease (PD) Trial in Rennes (BIA 9-1067 5 mg, BIA 9-1067 25 mg, levodopa/carbidopa 100/25)

            Completed
            • Parkinson's Disease (PD)
            • BIA 9-1067 5 mg
            • +4 more
            • Rennes, France
              BIOTRIAL
            Nov 19, 2015

            Parkinson's Disease (PD) Trial in S. Mamede do Coronado (BIA 9-1067, Warfarin)

            Completed
            • Parkinson's Disease (PD)
            • S. Mamede do Coronado, Trofa, Portugal
              BIAL - Portela & Cª - Human Pharmacology Unit (UFH)
            Nov 18, 2015

            Parkinson's Disease (PD) Trial in S. Mamede do Coronado (BIA 9-1067, Placebo, Madopar® HBS)

            Completed
            • Parkinson's Disease (PD)
            • BIA 9-1067
            • +2 more
            • S. Mamede do Coronado, Trofa, Portugal
              BIAL - Portela & Cª - Human Pharmacology Unit (UFH)
            Oct 2, 2015

            Parkinson's Disease (PD) Trial in Zuidlaren (OPC)

            Completed
            • Parkinson's Disease (PD)
            • Zuidlaren, Netherlands
              PRA
            Jul 22, 2015